Targeting ferritin receptors for the selective delivery of imaging and therapeutic agents to breast cancer cells-Reference-Cited by-同舟云学术

Targeting ferritin receptors for the selective delivery of imaging and therapeutic agents to breast cancer cells

Published:2015 Issue:15 Volume:7 Page:6527-6533
ISSN:2040-3364
Container-title:Nanoscale
language:en
Short-container-title:Nanoscale

Author:

Geninatti Crich S.¹²³,Cadenazzi M.¹²³,Lanzardo S.¹²³,Conti L.¹²³,Ruiu R.¹²³,Alberti D.¹²³,Cavallo F.¹²³,Cutrin J. C.¹²³,Aime S.¹²³

Affiliation:

1. University of Turin

2. Department of Molecular Biotechnology and Health Sciences

3. Torino, Italy

Abstract

Horse Spleen Apoferritin has been exploited to deliver simultaneously therapeutic and imaging agents to breast cancer cells via the ferritin transporting route. The selective uptake has been investigated by MRI, and exploited for the simultaneous delivery of Curcumin, a compound with strong anti-neoplastic and anti-inflammatory action.

Publisher

Royal Society of Chemistry (RSC)

Subject

General Materials Science

Link

http://pubs.rsc.org/en/content/articlepdf/2015/NR/C5NR00352K

Reference46 articles.

1. Breast Cancer in Young Women in Latin America: An Unmet, Growing Burden

2. The landscape of medical oncology in Europe by 2020

3. Capecitabine Versus Classical Cyclophosphamide, Methotrexate, and Fluorouracil As First-Line Chemotherapy for Advanced Breast Cancer

Cited by 69 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adapting Ferritin, a Naturally Occurring Protein Cage, to Modulate Intrinsic Agonism of OX40;Bioconjugate Chemistry;2024-04-09

2. The heavy subunit of ferritin stimulates NLRP3 inflammasomes in hepatic stellate cells through ICAM-1 to drive hepatic inflammation;Science Signaling;2024-04-02

3. Nanoformulation of the Broad-Spectrum Hydrophobic Antiviral Vacuolar ATPase Inhibitor Diphyllin in Human Recombinant H-ferritin;International Journal of Nanomedicine;2024-04

4. The recent advancements in protein nanoparticles for immunotherapy;Nanoscale;2024

5. Ferritin‐based drug delivery system for tumor therapy;BMEMat;2023-04-26